Remove FDA Approval Remove Manufacturing Remove Packaging
article thumbnail

LumiThera’s Valeda Photobiomodulation System Gets FDA Authorization for Dry AMD

XTalks

Unlike its counterpart, wet AMD, which involves abnormal blood vessel growth, dry AMD lacks effective, FDA-approved treatment options, leaving patients at risk of significant vision loss. AMD is a leading cause of vision loss for people aged 65 and older. percent among individuals aged 45 to 49 to 27.2 percent for those aged 80 to 85.

article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Pharmaceutical companies – and the FDA – are embracing FDCs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMO Moves: Regulatory catalysts for therapy manufacturing -January

Pharmaceutical Technology

In order to get a therapy to the market, pharma companies often outsource the drug manufacturing to specialist contract manufacturing organizations (CMOs). While Catalent Inc and PCI Pharma Services are in charge of the solid dose and packaging of Lupkynis, Lonza is manufacturing the small molecule API. EMA and NICE news.

article thumbnail

FDA approves GSK’s Blenrep for advanced multiple myeloma

pharmaphorum

GSK has not released information about its plans for pricing in the US, but antibody drugs tend to be less expensive than CAR-Ts, which are manufactured using a costly process that involves harvesting a patient’s cells and modifying them to fight cancer. Keratopathy leading to treatment discontinuation affected 2.1%

article thumbnail

In the News: October 2021 Regulatory and Development Updates

Camargo

FDA Publishes ICH Guidelines on Continuous Manufacturing. The FDA recently published the ICH’s Harmonised Guideline Q13, titled “ Continuous Manufacturing of Drug Substances and Drug Products.” Batch steps include filter drying, milling, and packaging.

article thumbnail

In the News: September 2021 Regulatory and Development Updates

Camargo

The pilot program is the first step in allowing manufacturers to receive a preliminary review of a novel excipient, prior to drug product formulation. Eligibility for the pilot program has been limited to excipients that 1) have not been previously used in FDA-approved drug products, and 2) do not have an established use in food.

article thumbnail

Pink Sauce: Everything You Need to Know About TikTok’s Controversial Condiment

XTalks

Yet over the past few weeks, she’s faced numerous questions about Pink Sauce’s ingredients, packaging and marketing, prompting a social media-based food scandal. Several other customers said they received leaking bottles of rotten-smelling sauce in the mail, with approximately 50 packages being impacted. FDA-Approved?